but Novo Nordisk is the first to make the technology available to NHS patients in the UK. Lilly is developing Tempo Smart Button, a device that attaches to its Tempo insulin delivery pen rang ...

Last October Novo Nordisk announced that it had ... formulation to be as effective as injectable insulin – and says a future advance in drug delivery could still make it a reality.

Nanexa AB announces that initial observations in the phase I study show that the 30 mg dose of NEX-22, a depot formulation of liraglutide, has been well tolerated by patients with type 2 diabetes who ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to ...